These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1815650)

  • 1. Hemodynamic responses to verapamil monotherapy in patients with renal disease.
    Lenz T; Müller FB; Sotelo JE; Laragh JH; August P
    Am J Hypertens; 1991 Dec; 4(12 Pt 1):939-43. PubMed ID: 1815650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic responses to converting enzyme inhibition in patients with renal disease.
    August P; Cody RJ; Sealey JE; Laragh JH
    Am J Hypertens; 1989 Aug; 2(8):599-603. PubMed ID: 2550029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of angiotensin-converting enzyme inhibition on altered renal hemodynamics induced by low protein diet in the rat.
    Fernández-Repollet E; Tapia E; Martínez-Maldonado M
    J Clin Invest; 1987 Oct; 80(4):1045-9. PubMed ID: 3308957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of short-term administration of cromakalim on renal hemodynamics and eicosanoid excretion in essential hypertension.
    Lebel M; Grose JH; Lacourcière Y
    Am J Hypertens; 1991 Sep; 4(9):740-4. PubMed ID: 1834087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased systemic and renal vascular sensitivity to angiotensin II in normotensive men with positive family histories of hypertension.
    Widgren BR; Herlitz H; Aurell M; Berglund G; Wikstrand J; Andersson OK
    Am J Hypertens; 1992 Mar; 5(3):167-74. PubMed ID: 1575943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic and renal effects of a new angiotensin converting enzyme inhibitor, benazepril, in essential hypertension.
    Valvo E; Casagrande P; Bedogna V; Antiga L; Alberti D; Zamboni M; Perobelli L; Dal Santo F; Maschio G
    J Hypertens; 1990 Nov; 8(11):991-5. PubMed ID: 1963190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal Hemodynamic Function and RAAS Activation Over the Natural History of Type 1 Diabetes.
    Lytvyn Y; Bjornstad P; Lovshin JA; Boulet G; Farooqi MA; Lai V; Tse J; Cham L; Lovblom LE; Weisman A; Keenan HA; Brent MH; Paul N; Bril V; Advani A; Sochett E; Perkins BA; Cherney DZI
    Am J Kidney Dis; 2019 Jun; 73(6):786-796. PubMed ID: 30799029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of sustained-release verapamil on hemodynamics and renal function of patients with moderate to severe chronic renal failure].
    Schohn D; Maarek M; Jahn H
    Presse Med; 1993 Nov; 22(37):1856-60. PubMed ID: 8115329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic hypotensive effects of verapamil in angiotensin hypertension are steroid independent.
    Lohmeier TE; Montani JP; Smith MJ; Rushing EL
    Hypertension; 1989 Mar; 13(3):273-82. PubMed ID: 2921081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Direct Renin Blockade on Renal & Systemic Hemodynamics and on RAAS Activity, in Weight Excess and Hypertension: A Randomized Clinical Trial.
    Kwakernaak AJ; Roksnoer LC; Lambers Heerspink HJ; van den Berg-Garrelds I; Lochorn GA; van Embden Andres JH; Klijn MA; Kobori H; Danser AH; Laverman GD; Navis GJ
    PLoS One; 2017; 12(1):e0169258. PubMed ID: 28118402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nadolol on systemic and renal hemodynamics in patients with renoparenchymal hypertension and various degrees of renal function.
    Valvo E; Gammaro L; Bedogna V; Cavaggioni M; Tonon M; Lupo A; Loschiavo C; Tessitore N; Oldrizzi L; Rugiu G
    Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):202-6. PubMed ID: 3710633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic and renal hemodynamic changes after two-month treatment with enalapril in patients with essential hypertension.
    Valvo E; Gammaro L; Bedogna V; Tonon M; Giorgetti P; Pica B; Antonini P; Tessitore N; Oldrizzi L; Rugiu C
    Int J Clin Pharmacol Ther Toxicol; 1987 Dec; 25(12):656-9. PubMed ID: 2830196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative renal hemodynamic effects of lisinopril, verapamil, and amlodipine in patients with chronic renal failure.
    August P; Lenz T; Laragh JH
    Am J Hypertens; 1993 Apr; 6(4):148S-154S. PubMed ID: 8389563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of iloprost, a prostacyclin analog derivative, on renal plasma flow, renal function, and renin-aldosterone system in humans.
    Angeli P; Gatta A; Caregaro L; Menon F; Sacerdoti D; Merkel C; Visoná A; Lusiani L; Pagnan A
    Clin Pharmacol Ther; 1988 Aug; 44(2):211-6. PubMed ID: 2456174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of verapamil on renal blood flow, renal function, and neurohormonal profiles in patients with moderate to severe hypertension.
    Kubo SH; Cody RJ; Covit AB; Feldschuh J; Laragh JH
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):38S-46S. PubMed ID: 3794764
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of light exercise on renal hemodynamics in patients with hypertension and chronic renal disease.
    Svarstad E; Myking O; Ofstad J; Iversen BM
    Scand J Urol Nephrol; 2002; 36(6):464-72. PubMed ID: 12623513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long term effects of sustained release verapamil on the renal and systemic haemodynamic parameters in hypertensive patients with mild to severe chronic renal failure.
    Schohn DC; Jahn HA; Maareck M
    Drugs; 1993; 46 Suppl 2():113-9; discussion 119-20. PubMed ID: 7512464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of nitric oxide in the arterial pressure and renal adaptations to long-term changes in sodium intake.
    Manning RD; Hu L; Reckelhoff JF
    Am J Physiol; 1997 Apr; 272(4 Pt 2):R1162-9. PubMed ID: 9140016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Verapamil alters the relationship between renal perfusion pressure and glomerular filtration rate and renin release: the mechanism of the antihypertensive effect.
    Lin HB; Young DB
    J Cardiovasc Pharmacol; 1988; 12 Suppl 6():S57-9. PubMed ID: 2468908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional blood flow and neurohormonal responses to milrinone in congestive heart failure.
    Cody RJ; Kubo SH; Covit AB; Müller FB; Rutman H; Leonard D; Laragh JH; Feldschuh J; Preibisz J
    Clin Pharmacol Ther; 1986 Feb; 39(2):128-35. PubMed ID: 3510799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.